Theriva Biologics, Inc. Common Stock, Value, Issued
Theriva Biologics, Inc. (TOVX) had Common Stock, Value, Issued of $45.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-11
- 2026-06-30: Common Stock, Value, Issued $45.00K.
- 2026-03-31: Common Stock, Value, Issued $45.00K.
- 2025-12-31: Common Stock, Value, Issued $34.00K.
- 2025-09-30: Common Stock, Value, Issued $9.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $45.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $45.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $34.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $9.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $8.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $3.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $3.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $23.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $18.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.00K 10-K · filed 2025-03-06 | $18.00K 10-K · filed 2024-03-25 |
| 2023-09-30 | $18.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $18.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $16.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $16.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $16.00K 10-K · filed 2023-03-30 | |
| 2022-06-30 | $16.00K 10-K · filed 2023-03-30 | |
| 2022-03-31 | $158.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $13.00K 10-K · filed 2023-03-30 | $132.00K 10-K · filed 2022-03-16 |
| 2021-09-30 | $132.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $132.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $132.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $29.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $20.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $19.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $18.00K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $17.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $17.00K 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $17.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $16.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $15.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $5.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $130.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $129.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $4.00K 10-K · filed 2019-02-27 | $129.00K 10-K · filed 2018-02-22 |
| 2017-09-30 | $129.00K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $128.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $118.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $117.00K 10-K · filed 2018-02-22 | |
| 2016-09-30 | $92.00K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $91.00K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $91.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $91.00K 10-K · filed 2017-03-02 | |
| 2015-09-30 | $91.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $73.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $73.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $72.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $58.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $58.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $58.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $58.00K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $45.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $45.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $45.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $44.00K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $33.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $33.00K 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $33.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $31.00K 10-K · filed 2013-04-16 | |
| 2011-09-30 | $28.13K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $28.00K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $23.00K 10-K/A · filed 2012-05-11 | $23.34K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |